| 0.0002 0 (0%) | 07-14 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
RiceBran Technologies, along with its associated companies, functions as a specialized purveyor of ingredients. Its core business revolves around the development, processing, and distribution of premium, wholesome, and nutrient-rich products, sourced primarily from rice and other select small grains. The company adeptly transforms raw rice bran into stabilized rice bran (SRB) and subsequently into a suite of high-value derivative products. These include RiBalance, a comprehensive nutritional offering created by refining SRB; RiSolubles, a carbohydrate and lipid-dense fraction extracted from RiBalance; RiFiber, an insoluble protein and fiber-rich byproduct of RiBalance; and the ProRyza range, encompassing various protein or protein/fiber formulations. These SRB and derivative products are highly nutritious and advantageous, packed with a beneficial blend of oils, proteins, carbohydrates, essential vitamins, minerals, fibers, and antioxidants, significantly boosting the nutritional profile of end-consumer goods. In addition to human food applications, the company's SRB products are also supplied as essential feed components within the animal nutrition sector. RiceBran Technologies serves a diverse clientele, including manufacturers in both the food and animal nutrition industries, as well as wholesalers and retailers, operating across both domestic (United States) and international markets. Established in 2000 and based in Tomball, Texas, the enterprise initially operated as NutraCea before rebranding as RiceBran Technologies in October 2012.
Sun, 12 Jul 2026
Enterprise value to EBITDA forward of RiceBran Technologies – OTC:RIBT - TradingView
Wed, 22 Jan 2025
RiceBran Technologies Expands MGI Grain to Meet Increasing Demand - ACCESS Newswire
Tue, 21 Jan 2025
RiceBran Technologies Secures Investment from Funicular Funds, LP - ACCESS Newswire
Thu, 20 Jul 2023
9 Consumer Staples Stocks Moving In Thursday's Pre-Market Session - Quantisnow
Mon, 26 Jun 2023
RiceBran Technologies Sells SRB Business - Yahoo Finance
Sun, 25 Jun 2023
Stabil Nutrition, LLC acquired Stabilized Rice Bran Business from RiceBran Technologies for $3.5 million. - marketscreener.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
OTC
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Packaged Foods
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|